Statin use and the risk of bladder cancer: a population-based case–control study

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Expert Opinion on Drug Safety

• Publication date

  2012-08-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14740338.2012.712960PMID 22849562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan

  2011cited by this paper
• Exposure to statins and risk of common cancers: a series of nested case-control studies

  2011cited by this paper
• Incidence of cancer and statin usage—Record linkage study

  2010cited by this paper
• Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort.

  2010cited by this paper
• Analgesic use and the risk for progression of chronic kidney disease

  2010cited by this paper
• Statins inhibit NK‐cell cytotoxicity by interfering with LFA‐1‐mediated conjugate formation

  2009cited by this paper
• The double-edged sword of statin immunomodulation.

  2009cited by this paper
• Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.

  2009cited by this paper
• Screening statins for possible carcinogenic risk: up to 9 years of follow‐up of 361 859 recipients

  2008cited by this paper
• The association between statins and cancer incidence in a veterans population.

  2008cited by this paper
• Statins and cancer: A systematic review and meta-analysis.

  2008cited by this paper
• The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells.

  2008cited by this paper
• Do statins prevent or promote cancer?

  2008cited by this paper
• Statins and risk of cancer: A systematic review and metaanalysis

  2007cited by this paper
• Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997–2003

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Epidemiological features of CKD in Taiwan.

  2007cited by this paper
• Statins and Cancer Risk: A Meta-analysis

  2007cited by this paper
• Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans.

  2007cited by this paper
• Statins Reduce the Risk of Pancreatic Cancer in Humans: A Case-Control Study of Half a Million Veterans

  2007cited by this paper
• Statin Use and the Risk of 10 Cancers

  2007influential reference
• Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.

  2006cited by this paper
• Statins and the Risk of Lung, Breast, and Colorectal Cancer in the Elderly

  2006cited by this paper
• Statins and osteoporosis: new role for old drugs

  2006cited by this paper
• Statins and cancer risk: a meta-analysis.

  2006cited by this paper
• Statins and the risk of colorectal cancer.

  2005cited by this paper
• Statins and prostate cancer risk: a case-control study.

  2005cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• The risk of cancer in users of statins.

  2004cited by this paper
• Statin use and cancer risk in the General Practice Research Database

  2004cited by this paper
• Hip fracture risk in statin users—a population-based Danish case-control study

  2004cited by this paper
• The association between 3‐hydroxy‐3‐methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women

  2004cited by this paper
• Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models.

  2003cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial

  2003cited by this paper
• Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study

  2003cited by this paper
• Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.

  2002cited by this paper
• 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Interfere With Angiogenesis by Inhibiting the Geranylgeranylation of RhoA

  2002cited by this paper
• Statins Have Biphasic Effects on Angiogenesis

  2002cited by this paper
• HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

  2002cited by this paper
• 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy

  2002cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002cited by this paper
• Statin Use and the Risk of Breast and Prostate Cancer

  2002cited by this paper
• 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.

  2002cited by this paper
• 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis.

  2002cited by this paper
• Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.

  2001cited by this paper
• 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study.

  2000cited by this paper
• HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.

  2000cited by this paper
• HMG-CoA reductase inhibitors and the risk of fractures.

  2000cited by this paper
• Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase.

  1999cited by this paper
• Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis

  1998cited by this paper
• Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.

  1997cited by this paper
• Carcinogenicity of lipid-lowering drugs.

  1996cited by this paper
• Carcinogenicity of lipid-lowering drugs.

  1996cited by this paper
• Effect of pravastatin on outcomes after cardiac transplantation.

  1995cited by this paper
• Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.

  1991cited by this paper

• Assessing the role of statin therapy in bladder cancer: evidence from a Mendelian Randomization study

  2024cites this paper
• Statin therapy and upper tract urothelial carcinoma risk in hyperlipidemic patients with chronic kidney disease and end-stage kidney disease, a population-based 17-year follow-up study

  2024cites this paper
• Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a Mendelian randomization study

  2023cites this paper
• Assessing the role of lipid-lowering therapy on multi-cancer prevention: A mendelian randomization study

  2023cites this paper
• The Effect of Statins on the Incidence and Prognosis of Bladder Cancer: A Systematic Review and Meta-Analysis

  2023cites this paper
• Effects of Aspirin, Nonsteroidal Anti-inflammatory Drugs, Statin, and COX2 Inhibitor on the Developments of Urological Malignancies: A Population-Based Study with 10-Year Follow-up Data in Korea

  2017cites this paper
• Tiotropium formulations and safety: a network meta-analysis

  2017cites this paper
• Association between Statin Use and Cancer: Data Mining of a Spontaneous Reporting Database and a Claims Database

  2015cites this paper
• Statins are potential anticancerous agents (review).

  2015cites this paper
• Common cancer risk and statins: a population-based case–control study in a Chinese population

  2013cites this paper
• Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.

  2013cites this paper
• Statin use and risk of bladder cancer: a meta-analysis

  2013cites this paper